US FDA approves Sanofi’s bleeding disorder therapy
By Sriparna Roy and Padmanabhan Ananthan (Reuters) -The U.S. Food and Drug Administration approved French drugmaker Sanofi’s hemophilia therapy, introducing…
By Sriparna Roy and Padmanabhan Ananthan (Reuters) -The U.S. Food and Drug Administration approved French drugmaker Sanofi’s hemophilia therapy, introducing…
By Jonathan Stempel (Reuters) – A federal judge ordered a Johnson & Johnson unit on Friday to pay the U.S.…
WASHINGTON (Reuters) -Billionaire Elon Musk, who serves as a top adviser to President Donald Trump, will visit the Central Intelligence…
By Krystal Hu and Jaspreet Singh (Reuters) – OpenAI must transition to a for-profit company by the end of the…
(Reuters) -The U.S. Food and Drug Administration’s top vaccine official, Peter Marks, has been pushed out, the Wall Street Journal…
By David Lawder and David Shepardson (Reuters) – Canada and Mexico won protections against potential new U.S. auto tariffs in…
WASHINGTON (Reuters) -The International Monetary Fund is continuing to assess the impact of President Donald Trump’s tariff plans, including his…
By Helen Reid LONDON (Reuters) -H&M’s sales were up just 1% in March after a weaker than expected first quarter,…
By Lananh Nguyen, Pete Schroeder and Tatiana Bautzer NEW YORK (Reuters) – U.S. banking giants are pushing for a swath…
By Max Hunder KHERSON, Ukraine (Reuters) – When he learned that U.S. President Donald Trump had suspended funding for a…